We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
32 hedge funds and large institutions have $23.6M invested in Madrigal Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
17% more capital invested
Capital invested by funds: $20.1M → $23.6M (+$3.5M)
3% more funds holding
Funds holding: 31 → 32 (+1)
1.59% more ownership
Funds ownership: 11.63% → 13.22% (+1.6%)
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$788K |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$786K |
| 3 |
Millennium Management
New York
|
+$497K |
| 4 |
Goldman Sachs
New York
|
+$328K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$314K |
